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RESUMO.- [Fatores de risco associados com a resistên-
cia antimicrobiana de Staphylococcus aureus isolados 
da mastite bovina.] Objetivou-se com este estudo avaliar os fatores de risco associados às práticas de manejo e tra-tamento de mastite e a resistência aos antimicrobianos de 
Staphylococcus aureus isolados de vacas com mastite. Fo-
ram selecionados para o presente estudo 13 rebanhos lo-calizados na região de Pirassununga/SP. Foi aplicado um questionário contendo informações para o levantamento de fatores de risco relacionados à resistência aos antimi-crobianos e às práticas de manejo e tratamento de mastite. Após a seleção dos rebanhos e aplicação dos questionários, foram utilizados 210 isolados de S. aureus de amostras compostas de leite coletadas durante 24 meses, em quatro períodos, para realização dos testes de resistência. Os anti-microbianos testados foram: ampicilina 10µg, clindamicina 2µg, penicilina 1µg, eftiofour 30µg, gentamicina 10µg, sul-
fatrimetropin 25µg, enrofloxacina 5µg, sulfonamida 300µg, 
tetraciclina 30µg, oxacilina 1µg, cefalotina 30µg e eritro-
micina 5µg. As variáveis que foram significativamente as-
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sociadas à resistência de S. aureus foram: o tratamento da mastite clínica para ampicilina (OR = 2,18), o tratamento 
da vaca seca para enrofloxacina (OR=2,11), e o não envio de amostras de leite para a cultura microbiológica e testes de sensibilidade, para ampicilina (OR=2,57) e penicilina 
(OR=4,69). Em conclusão, a identificação dos fatores de ris-co para a resistência S. aureus frente aos principais agentes antimicrobianos, utilizados para tratamento da mastite, 
pode auxiliar o estabelecimento do uso prudente de anti-microbianos na produção de leite.TERMOS DE INDEXAÇÃO: Fatores de risco, resistência antimicro-biana, Staphylococcus aureus, mastite bovina,  tratamento, práti-cas de manejo, in vitro susceptibilidade.
INTRODUCTIONMastitis is the most common disease in dairy herds and is the main cause of antibiotic use in adult dairy cows (Rue-gg 2009). On dairy farms, antimicrobials such as penicillin, cephalosporin, and tetracycline, among others, are used to treat and prevent mastitis that is caused by Gram-positive and Gram-negative bacteria (Oliver & Murinda 2012). Ho-
wever, the efficacy of these antimicrobials can be compro-mised by the emergence of antimicrobial resistance in the relevant mastitis pathogens, such as Staphylococcus aureus. The intensive use of antibiotics in human and veterinary medicine may increase bacterial resistance (Hawkey 2003). Thus, dairy farms and the current management practices employed for milk production might be associated with the dissemination of antibiotic-resistant bacterial strains (Acar & Moulin 2006).
Staphylococcus aureus is one of the most important cau-ses of clinical mastitis and is the pathogen that is most fre-quently isolated in cases of subclinical mastitis worldwide (Sampimon et al. 2009, Waage 1997). S. aureus is also the main microorganism investigated in antimicrobial suscep-tibility studies due to its high prevalence in dairy cow mas-titis (Malinowski et al. 2002). Additionally, staphylococcal food poisoning is caused by the ingestion of staphylococ-
cal enterotoxins, which are resistant to heat treatment and are generally produced by S. aureus strains (Roberson et al. 1994). Thus, S. aureus is responsible for major losses on dairy farms and is resistant to several of the antimicrobials that are routinely used in mastitis treatment (Freitas et al. 2005). Several mechanisms of resistance to the available antimicrobial drugs have been described; however, many aspects of antimicrobial resistance development and dis-semination remain uncertain. Resistance among mastitis pathogens has been reported for nearly four decades, but 
despite this, there is no scientific evidence to determine whether it is an emergent phenomenon or is in progress (Oliver et al. 2011).Some studies have evaluated the trends of antimicrobial resistance of mastitis-causing bacteria for various periods of time in different regions (Erskine et al. 2002, Myllys et al. 1998, Petrovski et al. 2011). The results of these studies indicated variation among the different regions studied; 
however, there is no scientific evidence of a significant in-crease in the antimicrobial resistance of mastitis-causing 
pathogens over time (Oliver et al. 2011). Some studies have reported that the susceptibility of S. aureus varied from 7 to 63% for penicillin (Guler et al. 2005, Watts & Salmon 1997) from 0 to 93% for erythromycin (Wang et al. 2008), from 0 to 28% for tetracycline (Guler et al. 2005, Watts & 
Salmon 1997), and from 4.5 to 7.5% for sulfadimethoxine (Makovec et al. 2003, Sabour et al. 2004). However, no stu-dies concerning the management- and treatment-associa-ted risk factors for the antimicrobial resistance of S. aureus in bovine mastitis are available. The objective of this study was to evaluate the association between the management practices and treatment procedures and the antimicrobial resistance of S. aureus that was isolated from bovine mas-titis samples.
MATERIALS AND METHODS
Selection of dairy herds and cow samplingThirteen out of 60 dairy herds from the members of the dairy industry located in Pirassununga (São Paulo State, Brazil) were selected according the number of lactating cows per herd, the 
herd’s milk production, a maximum distance of 80 km from the laboratory where the evaluation was performed and the farmers’ willingness to participate in this study. Selected dairy herds were randomly selected in the municipalities of Leme, Santa Rita do Passa Quatro, Descalvado, São João da Boa Vista and Pirassunun-ga. To determine the total number of herds to be included in this study, the number of milk samples required to estimate the fre-quency of Staphylococcus spp. antimicrobial resistance according to the recommendations described by the OIE (2008) was con-sidered. A variation in the prevalence of S. aureus antimicrobial 
resistance to penicillin of 35% (90% confidence interval: 33.4-36.7%) was used, based on the results reported by Brito et al. (1999). The number of milk samples collected per herd was based on the methodology of Frankena & Graat (1997) (Table 1).The on-farm data about the possible risk factors associated 
with antimicrobial susceptibility were collected during the first farm visit based on a questionnaire that included questions about mastitis treatment, prevention procedures, and herd manage-ment. Milk samples were collected on four different occasions over a period of two years (May 2010, August 2010, January 2011 and July 2011).
Bacteriological analysesComposite milk samples (40mL) from four mammary gland quarters of each selected cow were collected aseptically in a steri-le vial before milking. The milk samples were immediately cooled 
Table 1. Number of dairy herds and cows selected, according 
to the prevalence of Staphylococcus aureus antimicrobial 
resistance to penicillin Number of Herd Number of selected lactating cows frequency (%) Dairy herds Cows† 10-19 29 6 All cows 20-29 13 3 All cows 30-39 8 2 All cows or 30 if > 30 40-49 2 0 - 50-60 4 1 30 (randomization) >60 4 1 30 (randomization) Total 60 13 -† Considering a prevalence of S. aureus antimicrobial resistance to peni-
cillin of 35% (90% confidence interval: 33.4-36 (Britto et al. 1999).
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to 4°C, transported to the laboratory and stored at -20°C. Micro-biological analyses of the milk samples were performed as recom-mended by the National Mastitis Council (Oliver et al. 2004). A total of 10µl of milk was plated on 5% sheep blood agar and in-cubated at 37°C for 24 and 48 hours. The bacteriological cultures 
were classified as positive based on the presence of three or more identical colonies. The colony morphology and Gram-stain reac-tion of the bacterial isolates were analyzed. In the case of Gram--positive isolates, the catalase test was performed to distinguish 
Streptococcus spp. from Staphylococcus spp. In the case of Sta-phylococci, the coagulase test was performed to classify the bac-teria as coagulase positive or negative, and Voges-Proskauer test was performed on the coagulase positive Staphylococcus to iden-tify S. aureus. All of the bacterial isolates were cryopreserved in brain heart infusion broth (BHI, Becton, Dickinson and Company, Sparks, MD, USA) with 20% glycerol at -20°C for further analyses.
Antimicrobial susceptibility testingThe antimicrobial susceptibility tests of all of the Staphyl-
pococcus aureus isolates were performed using agar dilution as described by the Clinical and Laboratory Standards Institute (CLSI 2008). In brief, the isolates were inoculated in BHI broth and incubated for 24 hours at 36°C; subsequently, the turbidity of the cultures were standardized 0.5 on the MacFarland scale. All the standardized bacterial suspensions were plated over the en-tire surface of a plate of Mueller-Hinton agar using a sterile swab. 
Twelve antimicrobial discs (Oxoid, Basingstoke, England) were 
deposited on the medium with the aid of a dispenser (Oxoid, Ba-singstoke, England). The plates were incubated at 35oC, and the inhibition zones were measured after 18 hours of incubation. The inhibition zones were recorded in millimeters and were interpre-ted according to the criteria of the CLSI (2008). Quality control was also performed in accordance with Clinical and Laboratory Standards Institute guidelines using S. aureus ATCC 25923 and ATCC 29213, Escherichia coli ATCC 25922, Pseudomonas aerugi-
nosa ATCC 27853, Enterococcus faecalis ATCC 29212 and Strepto-
coccus pneumoniae ATCC 49619.The following antimicrobials were tested: ampicillin 10mg, 
clindamycin 2μg, penicillin 1μg, ceftiofur 30μg, gentamicin 10mg, 
sulfa-trimethoprim 25mcg, enrofloxacin 5μg, sulfonamide 300μg, 
tetracycline 30μg, oxacillin 1μg, cephalothin 30μg and erythromy-
cin 5μg.
Questionnaire about mastitis treatment and management 
practicesPreviously formulated questionnaires were submitted to the 
dairy herd manager during the first farm visit, which included questions about the following: the use of dry cow therapy; the mastitis treatment records; the use of treatment for clinical masti-tis cases; the therapeutic treatment record; the use and frequency of microbiological culture tests; and the use and frequency of anti-microbial susceptibility tests of the mastitis pathogens that were 
identified. The following additional information about the general 
herd characteristics was recorded: identification and location; number of lactating cows; total milk production; individual milk yield, and milking system.
Statistical analysesThe statistical analyses were performed using the Statistical Analysis System (SAS Institute Inc. 2010). The frequencies S. au-
reus isolates resistance was calculated using the chi-square test (PROC FREQ). Also, the frequencies of responses to the questio-nnaire for each antimicrobial that had been tested were analyzed using the chi-square test (PROC FREQ), considering a probability 
of ≤ 0.2 to screen for potential risk factors for the antimicrobial 
resistance of S. aureus that could be inserted into the logistic re-gression models. The other criteria that were used to select the variables for inclusion in the logistic regression model were those 
that offered a coherent biological explanation for an increase in S. 
aureus antimicrobial resistance. A multivariate logistic regression model (PROC LOGIT) was used determine risk factors at S. aureus positive samples level as described by Frankena & Graat (1997), 
using a probability of ≤0.05. The odds ratios were estimated using 
the respective confidence interval (CI) of 95%.
RESULTSIn this study, 77% of the herds that were evaluated were 
composed of crossbred cows (Holstein x Gir) and were composed of 23% of Holstein cows. The number of lacta-ting cows ranged from 11 to 90/herd and the milk yield ranged from 80 to 1000 liters/day / herd. Regarding the management characteristics, manual milking was perfor-med in four herds and mechanical milking was performed in 56 herds.A total of 1069 milk samples were collected and sub-jected to microbiological culture. Of these, 756 samples (70.7%) were culture-positive and 313 (29.3%) were culture-negative. The frequencies with which the mastitis--causing pathogens were isolated are as follows: 28.57% of coagulase-negative Staphylococcus (CNS) (n=216); 27.77% of S. aureus (n=210); 10.97% of Corynebacterium spp. (n=83); 8% of Streptococcus agalactiae (n=60); 6.2% of 
Streptococcus dysgalactiae (n=47); 6% of coagulase-positi-ve Staphylococcus (n=45); 3.2% of esculin-positive Strepto-
coccus (n=24); 4.9% of Arcanobacterium spp. (n=37), and 2.5% of Bacillus spp. (n=19).The on-farm potential risk factors for S. aureus antimi-crobial resistance according to the antimicrobial tested that 
were inserted into the final logistic regression model are presented in Table 2. The following risk factors for the anti-microbial resistance of S. aureus were identified (Table 3): ampicillin- treatment of clinical mastitis cases (OR=2.18) and not sending milk samples for microbiological culture 
and antimicrobial susceptibility tests (OR=2.57); enroflo-
xacin- dry cow treatment (OR=2.11); penicillin- not sen-ding milk samples for microbiological culture and antimi-crobial susceptibility tests (OR=4.69).The risk of S. aureus resistance on farms that did not send samples for culture and susceptibility tests was also higher for penicillin (OR=4.69) and ampicillin (OR=2.57) compared with S. aureus isolated from farms that performed this prac-
tice. In this study, the treatment of mastitis was identified as a risk factor for S. aureus resistance to ampicillin. S. aureus isolates from farms on which all of the clinical mastitis cases were routinely treated were 2.18 times more likely to be re-sistant to ampicillin than were S. aureus isolates from farms on which clinical mastitis was not treated. Additionally, the 
practice of dry cow treatment was identified as a risk factor for S. aureus resistance to enrofloxacin and penicillin. Farms using dry cow treatment had 2.11 times greater chances to have S. aureus that was resistant to enrofloxacin than did farms where this practice was not employed.
On the other hand, a protective factor identified in this study for S. aureus antimicrobial resistance was not using 
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a mastitis treatment protocol for clinical mastitis cases. S. 
aureus isolates from farms that did not use this treatment protocol were 0.45 times more likely to be resistant to te-tracycline than were S. aureus isolates from farms that used a mastitis treatment protocol. The factors that showed a odds ratio < 1 were considered as protective factors.
DISCUSSIONThis study evaluated the association between herd mana-gement and the treatment practices for mastitis in dairy cows and the resistance of Staphylococcus aureus to an-timicrobial agents. According to the logistic regression model, the OR of Staphylococcus aureus resistance to peni-cillin and ampicillin was higher on farms that did not sen-di milk samples for microbiological culture and suscepti-bility tests. Hoe & Ruegg (2006) reported that the use of microbiological culture testing for mastitis diagnosis was also associated with the size of the herd. These authors re-ported a total of 38.9% of the farms with large herds had culture tests performed for all of the clinical mastitis ca-ses, compared with the farms with smaller herds. On farms with medium and large herds, it was 2-3 times more likely that bulk tank cultures to identify mastitis pathogens were performed compared with on farms with smaller herds, and 49% of the farms with smaller herds had never had microbiological bulk tank cultures conducted. According to Hoe & Ruegg (2006), the larger farms had more access 
to bulk tank diagnostic methods than did the farms with smaller herds.
The practice of dry cow treatment was identified as a risk factor for S. aureus resistance to enrofloxacin. Studies of the association between dry cow therapy and the deve-lopment of antimicrobial resistance in mastitis pathogens are limited. Pol & Ruegg (2007) evaluated the relationship between antimicrobial use and the susceptibility of Gram--positive mastitis pathogens in organic and conventional dairy herds. In that study, the antimicrobials that were most frequently used for dry cow treatment were penicillin, streptomycin and tetracycline (90%), and the daily doses of these antimicrobials was calculated at the mammary quar-ter level. S. aureus isolates from the conventional herds were 7.7 times more likely to be resistant to ampicillin and 6.3 times more likely to be resistant to penicillin compared to the isolates from the organic farms (Pol & Ruegg 2007). The differences in the resistance on the conventional farms were attributed to the intramammary treatment of clinical mastitis (66%) and dry cow treatment (44%). In addition, the isolates from multiparous cows were more likely to be resistant than were the isolates from primiparous cows. 
These observations suggested that long-term exposure to 
antimicrobials (for example, continuous use of dry cow tre-
atment) significantly increases the level of antimicrobial resistance (Pol & Ruegg 2007), as observed in the present study.
Table 2. Staphylococcus aureus antimicrobial resistance frequencies according to 
antimicrobial and evaluated risk factors Antimicrobial Total of resistant (%) Questionnaire questions Resistant (%) P† Ampicillin 71 (33.8)  Use of clinical mastitis treatment 56 (78.9) 0.005   Not sending milk samples for microbiological 56 (78.9) 0.003   culture and susceptibility tests Ceftiofur 57 (27.1) Use of clinical mastitis treatment 43 (75.4) 0.048   Not respecting the withdrawal periods 46 (80.7) 0.011
 Enrofloxacin 34 (16.2) Use of dry cow treatment 17 (50.0) 0.049 Erythromycin 10 (4.8) Not sending milk samples for microbiological 7 (70.0) 0.070   culture and susceptibility tests   Not using a mastitis treatment protocol 7 (70.0) 0.165 Gentamicin 38 (18.1) Use of clinical mastitis treatment 29 (76.3) 0.145   Not keeping records of mastitis treatment  32 (84.2) 0.189
 Oxacillin 25 (11.9) Use of clinical mastitis treatment 13 (52.0) 0.110   Use of dry cow treatment 6 (24.0) 0.066   Not using a mastitis treatment protocol 18 (72.0) 0.013 Penicillin 60 (28.6) Use of clinical mastitis treatment 34 (56.7) 0.065   Use of dry cow treatment 39 (50.0) 0.016   Not sending milk samples for microbiological 50 (83.3) 0.178   culture and susceptibility tests   Not using a mastitis treatment protocol 39 (65.0) 0.003   Not keeping records of mastitis treatment 58 (96.7) 0.042 Sulfa-trimethoprim 35 (16.7) Use of clinical mastitis treatment 17 (50.0) 0.029   Not sending milk samples for microbiological 33 (97.1) 0.078   culture and susceptibility tests   Not using a mastitis treatment protocol 20 (61.8) 0.093 Sulfonamide 30 (14.3) Use of clinical mastitis treatment 17 (56.67) 0.004   Not using a mastitis treatment protocol 19 (63.3) 0.081 Tetracycline 19 (9.0) Use of dry cow treatment 11 (57.9) 0.115   Not sending milk samples for microbiological 11 (57.9) <0.001   culture and susceptibility tests   Not respecting the withdrawal periods 4 (21.0) 0.115   Not using a mastitis treatment protocol 12 (63.2) 0.182† P = probability calculated using the chi-squared test.
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Rajala-Schultz et al. (2009) determined both the pre-valence of antimicrobial resistance of coagulase-negative staphylococci (CNS) isolates before and after dry cow tre-atment and the diversity and persistence of this group of microorganisms during the dry cow period. These authors reported a strong association between antimicrobial re-sistance to most beta-lactam antibiotics and the age of the animals, dry cow treatment, high somatic cell counts and a history of clinical mastitis. Similarly, in the present study, one of the main risk factors for the antimicrobial resistance of S. aureus was dry cow treatment.Treatment of mastitis is the major reason for antimicro-bial use in dairy herds (Sawant et al. 2005). Guidelines on the prudent and judicious use of antimicrobials have recen-tly been developed by international organizations, inclu-ding the World Health Organization (WHO) and the Inter-national Organization of Epizooties (OIE 2008). As part of 
good veterinary practice, these guidelines aim to maximize 
therapeutic efficacy and minimize the selection of resistant organisms. Sawant et al. (2005) described some of these practices, including record keeping and the treatment pro-tocols for cases of mastitis.In this study, the practice of not using a mastitis treat-
ment protocol for clinical mastitis cases was identified as a 
protective factor identified for S. aureus tetracycline resis-tance. According to Hoe & Ruegg (2006), written treatment protocols are recommended to establish practices and treatment decisions. In a study that Hoe & Ruegg (2006) conducted in Wisconsin (USA), a written protocol for the treatment of mastitis was highly associated with the herd size (P<0.001). Most of the farmers in that study had large herds (75%) and reported that they maintained a written protocol for the treatment of mastitis, compared with 29 and 21% of the farmers with medium or small herds, res-pectively. Regardless of the herd size, 60% of the treatment 
protocols were written by a veterinarian, approximately 30% of the treatment protocols were written by farm ma-nagers and less than 1% of the treatment protocols were from the pharmaceutical companies.Some of the limitations of the present study were the small number of herds sampled (n=13) and the small num-ber of variables tested (n=6). Therefore, careful considera-tion should be taken when comparing the data presented in this study with the data from other studies. Additionally, 
the results of this study are from a specific Brazilian region and may be not representative of the entire country. Thus, 
future studies may discover the profile of trends in antimi-crobial resistance in Brazilian dairy herds.
There was an association between the resistance of S. 
aureus to antimicrobials and the management practices and mastitis treatment on the farms. The results of the present study suggest that the frequency of Staphylococcus 
aureus resistance is greater for ampicillin than other anti-microbial tested. Additionally, Staphylococcus aureus resis-tance for penicillin is higher in dairy farms that do not send milk samples for microbiological culture and susceptibility 
tests. The identification of risk factors for S. aureus resis-tance against various mastitis antimicrobials is an impor-tant information that helps in practical recommendations for a prudently antimicrobial use in milk production.
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